Guiping Chen
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 4
- Bone Metabolism and Diseases 4
-
- MicroRNA in disease regulation 4
- Co-authors
- Min Dai (4 shared papers)Xuqiang Liu (4 shared papers)Qiang Xu (4 shared papers)Bin Zhang (3 shared papers)Sidan Tian (1 shared paper)Liang Luo (1 shared paper)Yiyi Zhang (1 shared paper)Jiasheng Tu (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (3 papers)Nature Communications (2 papers)Frontiers in Pharmacology (2 papers)Journal of Assisted Reproduction and Genetics (1 paper)BioMed Research International (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Guiping Chen
26 papers receiving 492 citations
Guiping Chen's Hit Papers
Peers
Comparison fields: 5 of 84
- Cancer Research 67
- Molecular Medicine 17
- Biomaterials 43
- Molecular Biology 214
- Analytical Chemistry 28
Countries citing papers authored by Guiping Chen
This map shows the geographic impact of Guiping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiping Chen more than expected).
Fields of papers citing papers by Guiping Chen
This network shows the impact of papers produced by Guiping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiping Chen. The network helps show where Guiping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Guiping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reactive oxygen species-responsive and Raman-traceable hydrogel combining photodynamic and immune therapy for postsurgical cancer treatment Hit paper breakdown → | 2022 | 139 |
| 2 | 2018 | 49 | |
| 3 | 2021 | 46 | |
| 4 | 2016 | 34 | |
| 5 | 2012 | 30 | |
| 6 | 2013 | 30 | |
| 7 | 2023 | 25 | |
| 8 | 2018 | 22 | |
| 9 | 2021 | 18 | |
| 10 | 2018 | 18 | |
| 11 | 2021 | 16 | |
| 12 | 2022 | 15 | |
| 13 | 2010 | 10 | |
| 14 | E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma. | 2011 | 8 |
| 15 | Curcumin combined with cis-platinum promote the apoptosis of human colorectal cancer HT29 cells and mechanism. | 2017 | 8 |
| 16 | 2024 | 5 | |
| 17 | 2012 | 4 | |
| 18 | 2024 | 4 | |
| 19 | 2021 | 3 | |
| 20 | 2020 | 3 |
About Guiping Chen
Guiping Chen is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Biomedical Engineering, having authored 28 papers that have together received 496 indexed citations. Recurring topics across this work include Circular RNAs in diseases (4 papers), Bone Metabolism and Diseases (4 papers), MicroRNA in disease regulation (4 papers), Biosensors and Analytical Detection (3 papers), Bone health and treatments (3 papers), Ferroptosis and cancer prognosis (2 papers), Head and Neck Cancer Studies (2 papers) and Analytical chemistry methods development (2 papers). The work is most often cited by research in Cancer Research (67 citations), Molecular Medicine (17 citations), Biomaterials (43 citations), Molecular Biology (214 citations) and Analytical Chemistry (28 citations). Guiping Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Min Dai, Xuqiang Liu, Qiang Xu, Bin Zhang, Sidan Tian, Liang Luo, Yiyi Zhang, Jiasheng Tu, Liping Huang and Yuan Lü. Their work appears in journals such as Biochemical and Biophysical Research Communications, Nature Communications, Frontiers in Pharmacology, Journal of Assisted Reproduction and Genetics and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.